Océanie · Actualité générale · The Australian

Orthocell partner receives US FDA clearance for marine-derived bone graft

Publié par The Australian · Australie il y a 10 h

Orthocell’s strategic partner Marine Biomedical has received US Food and Drug Administration (FDA) 510(k) clearance for PearlBone, a next-generation bone substitute developed…

Lire l'article complet sur The Australian Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.theaustralian.com.au)

Orthocell partner receives US FDA clearance for marine-derived bone graft

À lire aussi

Melbourne Cup LIVE: Point Of Law wins the Melbourne Cup ahead of Zahrann and Juja Kibo

Melbourne Cup LIVE: Point Of Law wins the Melbourne Cup ahead of Zahrann and Juja Kibo

ClearVue plants Hong Kong flag in Asian solar expansion

Economic outlook darkens in latest RBA forecasts

European Car of the Year 2027: All seven finalists are electric cars

Andrew Leigh: Why modern methods of construction needs to move from novelty to the norm

Orthocell partner receives US FDA clearance for marine-derived bone graft

Partager

À lire aussi

Melbourne Cup LIVE: Point Of Law wins the Melbourne Cup ahead of Zahrann and Juja Kibo

Melbourne Cup LIVE: Point Of Law wins the Melbourne Cup ahead of Zahrann and Juja Kibo

ClearVue plants Hong Kong flag in Asian solar expansion

Economic outlook darkens in latest RBA forecasts

European Car of the Year 2027: All seven finalists are electric cars

Andrew Leigh: Why modern methods of construction needs to move from novelty to the norm